Trial Profile
A multicentre, multinational, randomised, double blind, single dummy, parallel group, placebo-controlled trial to investigate the dose-response and safety of Fentanyl TAIFUN 100 µg, 200 µg, 400 µg in the treatment of breakthrough pain in patients with cancer on maintenance opioid therapy for persistent pain.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Sep 2022
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary) ; Fentanyl
- Indications Cancer pain
- Focus Therapeutic Use
- Acronyms FIND
- Sponsors LAB Pharma
- 22 Nov 2005 New trial record.